Astria Therapeutics, Inc. , a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare and niche allergic, and immunological diseases in the United States.
Astria Therapeutics stock last closed at $4.11, up 1.73% from the previous day, and has decreased 58.06% in one year. It has overperformed other stocks in the Biotechnology industry by 0.19 percentage points. Astria Therapeutics stock is currently +15.61% from its 52-week low of $3.56, and -68.19% from its 52-week high of $12.92.
As of Apr 21, 2025, there are 56.43M shares of ATXS outstanding. The market cap of ATXS is $231.94M. In the last 24 hours, 450,448 ATXS shares were traded.
You will need a brokerage account to access the NASDAQ market and buy ATXS shares.
Based on our research, eToro is the best brokerage. Here's why:
Get $10 towards your purchase of stock by opening an account with eToro now. This offer is only for US users.
Open eToro AccountNow that you've selected the right brokerage, it's time to fill out some personal information so you can buy ATXS today.
Now that you've finished signing up on our top ranked stock market app, you need to deposit funds:
Watch this video walkthrough for more details depositing money into your investment account.
After you have selected the best place to buy Astria Therapeutics stock, it's critical to research their stock before you buy, so you actually understand the risk and opportunity.
WallStreetZen was designed to help everyday investors do more accurate fundamental analysis quickly.
You can view all of the due diligence checks on ATXS's stock page.
You can use many financial metrics, analyses, models, and charts to gauge ATXS's true value.
Using relative valuations measures:
You can access additional valuation research on ATXS's stock here.
Out of 4 sell side analysts who give ratings on ATXS, the consensus analyst rating on Astria Therapeutics is a Buy
It's important to note that analyst ratings are not stock recommendations, nor are they financial advice.
You can dive deeper into what analysts are saying on the Astria Therapeutics stock forecast page.
Over the past 12 months, executives and large shareholders at ATXS have not bought or sold any shares.
Learn more about who owns ATXS shares here.
No, Astria Therapeutics doesn't provide an income stream by paying out dividends.
One of the reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to learn what other investors have to say.
You have two main order types:
Press the Open button and your broker will place the order.
If you need more help with investing in stocks on eToro, watch the helpful video below:
Now that you own some shares in ATXS, you'll want to stay up-to-date on your new company.
Put ATXS on a watchlist to see the latest developments about your ATXS stock.
To summarize, here are the 6 steps to buy Astria Therapeutics stock:
If you are looking for a brokerage account, eToro is our recommended option.
Get Started with eToro TodayIf you want to keep track of your new investment in Astria Therapeutics, click the button below.